Skip to main content

Table 2 Baseline characteristics of patients with diabetes and uncontrolled diabetes receiving care at a mobile medical clinics in Southern California between January 1, 2018, and December 31, 2019

From: Factors associated with mobile medical clinic use: a retrospective cohort study

Variables

Diabetes Yesa

Uncontrolledb Hemoglobin A1c ≥ 6.5

TOTAL SAMPLE*

117 (28.5)

69 (59.0)

Predisposing variables

 Gender/Sex

  Female

80 (68.4)

47 (68.1)

  Male

37 (31.6)

22 (31.9)

Race/Ethnicity

 Hispanic

96 (82.1)

57 (82.6)

 African American

3 (2.6)

1 (1.4)

 White

6 (5.1)

3 (4.3)

 Unspecified

12 (10.3)

8 (11.6)

Age

 25–35

1 (0.9)

0 (0.0)

 36 -45

22 (18.8)

14 (20.3)

 46–55

28 (23.9)

13 (18.8)

 56–65

49 (41.9)

31 (44.9)

 66 + 

17 (14.5)

11 (15.9)

 Mean (SD)

55.54 (10.0)

56.41(10.3)

Marital Status

 Married

67 (57.3)

39 (56.5)

 Single

28 (23.9)

14 (20.3)

 Unknown

22 (18.8)

16 (23.2)

Enabling variables

 Insurance Status

  Uninsured

60 (51.3)

41 (59.4)

  Unknown

53 (45.3)

25 (36.2)

  Other

4 (3.4)

3 (4.3)

Housing Status

 Housed

117 (100.0)

69 (100.0)

 Homeless

0 (0.0)

0 (0.0)

Clinic Location

 Ontario

46 (39.3)

28 (40.6)

 Fontana

44 (37.6)

29 (42.0)

 Muscoy

20 (17.1)

9 (13.0)

 San Bernardino

7 (6.0)

3 (4.3)

Need variables

 Chronic Illness

  Hypertension

82 (70.1)

50 (72.5)

  Diabetes

117 (100.0)

69 (100.0)

Other Medical Conditions

 Obesity

32 (27.4)

21 (30.4)

 Depression

1 (0.9)

1 (1.4)

Charlson Comorbidity Index Score

 0

9 (7.7)

2 (2.9)

 1

30 (25.6)

18 (26.1)

 2

37 (31.6)

23 (33.3)

 3

30 (25.6)

20 (29.0)

 4 + 

11 (9.4)

6 (8.7)

  1. aDiabetes Yes = Had a written diagnosis of diabetes in the chart, recorded hemoglobin A1c > 6.5, or was taking diabetes medication (i.e., metformin, glipizide)
  2. bDiabetes Uncontrolled = hemoglobin A1c > 6.5 at the start of the study
  3. *Row Percent